NEW YORK (GenomeWeb) – BG Medicine said today that it has amended its agreement with Abbott Laboratories for licensing and distributing its galectin-3 test.

The amendment changes product fees Abbott pays to BG Medicine for galectin-3 tests it sells to reference laboratories. In addition, Abbott was to make a payment of $500,000 to BG Medicine by November 30 and will make another $500,000 payment by June 30, 2016, provided certain commercial milestones are met.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.